NEW YORK, July 29, 2026, 16:00 EDT
- Shares of Humana fell 6.8% to $362.16 approaching the closing bell.
- Exits set for 2027 could impact 600,000 members. Humana anticipates recapturing roughly 40%.
- Adjusted profit for the quarter exceeded expectations. Guidance for full-year adjusted earnings was kept at a minimum of $9.00.
Shares of Humana Inc. NYSE:HUM dropped on Wednesday, even after the company surpassed quarterly profit forecasts. The maintained guidance put the focus on a more substantial Medicare Advantage pullback projected for 2027.
The upcoming departures will impact close to 600,000 Medicare Advantage members. This represents 9.3% of Humana’s 6.454 million individual-plan members as of June. The number also amounts to 49.8% of the 1.204 million members added following December.
Humana anticipates reclaiming approximately 40%, or nearly 240,000 members, through different plans. Nonetheless, the expected churn reflects management’s focus on restoring margins over maintaining volume. Humana is aiming for a stable pretax Medicare Advantage margin of no less than 3% by 2028.
The quarter highlighted the importance of that trade-off.
| Measure | Current figure | Comparison | Change or exposure |
|---|---|---|---|
| Consolidated revenue | $40.87 billion | $32.39 billion | up 26.2% |
| Adjusted EPS | $7.61 | $6.27 | increased 21.4% |
| Insurance benefit ratio | 91.2% | 89.9% | higher by 1.3 percentage points |
| Adjusted operating-cost ratio | 9.7% | 10.9% | lower by 1.2 percentage points |
| Individual MA membership | 6.454 million | 5.229 million | jumped 23.4% |
| Members in planned 2027 exits | About 600,000 | Current individual MA base | 9.3% |
Company disclosures provide the financial and membership data. The 9.3% exposure figure is based on June individual Medicare Advantage enrollment.
Revenue increased at a higher rate than earnings. Adjusted earnings reached $7.61 per share, surpassing the $7.22 LSEG consensus estimate. Despite this, Humana maintained its minimum full-year adjusted EPS outlook at $9.00.
The benefit ratio, representing premiums allocated to care, deteriorated by 1.3 percentage points. Meanwhile, the adjusted operating-cost ratio saw a 1.2-point improvement. Scale continues to benefit overhead, but claims persist as the limiting factor.
Humana reported that new enrollees have higher benefit ratios compared to existing members. An increase in the ratio was also attributed to reduced revenue from Star ratings. Trends in medical and pharmacy costs stayed within the high single-digit range.
Barclays analyst Andrew Mok stated the results “likely fell short of elevated investor expectations.” Humana’s shares had risen roughly 60% in the last three months. Reuters
Peer reports had set higher expectations. UnitedHealth Group Inc. NYSE:UNH lifted its 2026 guidance on July 16 following improved expense management. Humana kept its main forecast unchanged.
Humana lowered its reported, or GAAP, EPS minimum to $6.52 from $8.36. The company anticipates third-quarter adjusted EPS will be close to negative $1.00. The insurance benefit ratio is projected to increase just above 94%.
Chief Executive Jim Rechtin stated that “the first half of the year went well.” He noted that Humana was aligned with management’s expectations following the previous year’s investor day. SEC
Star ratings continue to be the key factor over time. CMS calculates 2026 ratings to set quality-bonus payouts for 2027. Humana’s initial estimate in October suggested that 20% of its members are enrolled in plans rated four stars or above. The company stated that diversification across contracts is expected to reduce its risk for that payout year.
Risks persist. Humana may not regain as many members as expected. Medical costs could outpace pricing, and uncertainty around Star thresholds may push back margin recovery.
The company’s next scheduled milestone is a virtual investor update taking place on December 10. In the meantime, the composition of the 2027 plan holds greater significance than the latest quarterly outperformance.
